Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
153 hedge funds and large institutions have $1.47B invested in Amedisys in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 26 closing their positions.
108% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $1.33M
7% less capital invested
Capital invested by funds: $1.57B → $1.47B (-$106M)
9% less funds holding
Funds holding: 168 → 153 (-15)
19% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 64
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$44.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$40.5M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$27.5M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$20.4M |
| 5 |
O
OppenheimerFunds
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.2M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.9M |
| 4 |
Renaissance Technologies
New York
|
-$13.2M |
| 5 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$6.98M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BWP
176
Baldwin Wealth Partners
Marion,
Massachusetts
| – | -$28K | -558 | Closed |
|
177
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$9K | -176 | Closed |
|
|
MWP
178
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| – | -$2K | -38 | Closed |
|
|
QCG
179
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1.15K | -23 | -56% |
|
AMED Hedge Fund Activity: Q3 2016 in Review
153 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2016, worth a combined $1.47B — down 6.7% from $1.57B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AMED and 13 opened new positions — a net loss of 13 holders — while 64 trimmed existing stakes and 52 added.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $44.7M. The largest seller was Fidelity Investments, cutting an estimated $29.2M.
- 153 institutional investors held Amedisys (AMED) as of Q3 2016, down from 168 in Q2 2016.
- Funds reported $1.47B of Amedisys stock for Q3 2016, down 6.7% quarter-over-quarter.
- 13 funds opened new Amedisys positions in Q3 2016 and 26 closed out, a net change of -13 holders.
- The largest Amedisys buyer in Q3 2016 was Gilder Gagnon Howe & Co, an estimated $44.7M added.
- The largest Amedisys seller in Q3 2016 was Fidelity Investments, an estimated $29.2M sold.
Based on aggregated 13F filings for Q3 2016.